These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12006970)

  • 1. Failure of naloxone to reverse brimonidine-induced coma in an infant.
    Sztajnbok J
    J Pediatr; 2002 Apr; 140(4):485-6; author reply 486. PubMed ID: 12006970
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic adverse effects of topical treatment with brimonidine in an infant with secondary glaucoma.
    Korsch E; Grote A; Seybold M; Soditt V
    Eur J Pediatr; 1999 Aug; 158(8):685. PubMed ID: 10445353
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers.
    Mungan NK; Wilson TW; Nischal KK; Koren G; Levin AV
    J AAPOS; 2003 Feb; 7(1):69-70. PubMed ID: 12690374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charles Bonnet syndrome precipitated by brimonidine tartrate eye drops.
    Tomsak RL; Zaret CR; Weidenthal D
    Br J Ophthalmol; 2003 Jul; 87(7):917. PubMed ID: 12812898
    [No Abstract]   [Full Text] [Related]  

  • 5. The teardrop sign: a rare dermatological reaction to brimonidine.
    Scruggs JT; Whiteside-Michel J; Brodsky MC
    Br J Ophthalmol; 2000 Jun; 84(6):671-2. PubMed ID: 10896417
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic brimonidine before LASIK.
    Uretmen O; Ates H; Andaç K
    J Refract Surg; 2003; 19(5):612. PubMed ID: 14518756
    [No Abstract]   [Full Text] [Related]  

  • 7. A 24-day old with episodic lethargy, hypotonia, and apnea: the eyes have it.
    Prok L; Hall D
    Curr Opin Pediatr; 2003 Apr; 15(2):226-8. PubMed ID: 12640283
    [No Abstract]   [Full Text] [Related]  

  • 8. A paradoxical ocular effect of brimonidine.
    Mushtaq B; Sardar J; Matthews TD
    Am J Ophthalmol; 2003 Jan; 135(1):102-3. PubMed ID: 12504711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anterior uveitis and topical brimonidine: a case report].
    Velasque L; Ducousso F; Pernod L; Vignal R; Deral V
    J Fr Ophtalmol; 2004 Dec; 27(10):1150-2. PubMed ID: 15687926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible cicatricial ectropion precipitated by topical brimonidine eye drops.
    Aristodemou P; Baer R
    Ophthalmic Plast Reconstr Surg; 2008; 24(1):57-8. PubMed ID: 18209648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic toxicity from subcutaneous brimonidine injection successfully treated with naloxone.
    Tobarran N; Kershner E; Chambers A; Cumpston KL; Wills BK
    Am J Emerg Med; 2022 Sep; 59():218.e5-218.e6. PubMed ID: 35835657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent central nervous system depression in infants after the use of topical brimonidine.
    Carlsen JO; Zabriskie NA; Kwon YH; Barbe ME; Scott WE
    Am J Ophthalmol; 1999 Aug; 128(2):255-6. PubMed ID: 10458196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update in glaucoma: the new pharmacotherapies. Brimonidine versus apraclonidine.
    Crichton AC
    Can J Ophthalmol; 1998 Aug; 33(5):254-5; discussion 257-8. PubMed ID: 9740952
    [No Abstract]   [Full Text] [Related]  

  • 14. Brimonidine tartrate poisoning in children: frequency, trends, and use of naloxone as an antidote.
    Lai Becker M; Huntington N; Woolf AD
    Pediatrics; 2009 Feb; 123(2):e305-11. PubMed ID: 19124581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brimonidine hypersensitivity when switching between 0.2% and 0.15% formulations.
    Sullivan-Mee M; Pensyl D; Alldredge B; Halverson K; Gerhardt G; Qualls C
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):355-60. PubMed ID: 20653479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic side effects of ophthalmic drops.
    Levy Y; Zadok D
    Clin Pediatr (Phila); 2004; 43(1):99-101. PubMed ID: 14968900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone in the reversal of coma induced by sodium valproate.
    Montero FJ
    Ann Emerg Med; 1999 Mar; 33(3):357-8. PubMed ID: 10036355
    [No Abstract]   [Full Text] [Related]  

  • 18. Is brimonidine ophthalmic a safe therapy for infants?
    Daubert GP
    J Clin Pharm Ther; 2006 Jun; 31(3):289-92. PubMed ID: 16789995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe systemic toxicity caused by brimonidine drops in an infant with presumed juvenile xanthogranuloma.
    Walters G; Taylor RH
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():797-8. PubMed ID: 10707152
    [No Abstract]   [Full Text] [Related]  

  • 20. [The ocular hypotensive effect and safety of 0.2% brimonidine].
    Yu M; Li Y; Ge J
    Yan Ke Xue Bao; 2001 Dec; 17(4):235-8. PubMed ID: 12567513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.